One Rock Capital Partners, a mid-market private equity firm, is weighing options for portfolio company Innophos Holdings, including a sale that could value the maker of food additives at more than $3bn, according to people familiar with the matter.
The private equity firm is working with advisers to explore strategic options for Cranbury, New Jersey-based Innophos, said the people, who asked to not be identified because the discussions are private. No decisions have been made and One Rock could elect to keep the business, the people said.
Representatives for One Rock and Innophos didn’t respond to requests seeking comment.
Get the week’s top news delivered directly to your inbox – Sign up for our newsletter
A sale would represent a relatively fast turnaround for One Rock, which acquired Innophos in 2020 for about $932 million, including debt. Private equity firms typically hold onto companies for three to five years.
Innophos, with operations throughout North America and China, makes ingredients for improving the taste and texture of products including cheese, baked goods and sports drinks, with brands including Bergavit, Cransmart and Oxyjun, according to its website.
One Rock, with offices in New York and Los Angeles, also owns stakes in companies including North Pacific Paper Co. and OLM Food Solutions, according to its website.
Source: BNN Bloomberg
Can’t stop reading? Read more
CapVest-backed IPN acquires premium pet food producer Sopral from Parquest
CapVest-backed IPN acquires premium pet food producer Sopral from Parquest CapVest Partners has...
Coller Capital secures record $6.8bn for private credit secondaries fund
Coller Capital secures record $6.8bn for private credit secondaries fund Coller Capital has closed...
Ardian exits landmark Paris asset following successful repositioning strategy
Ardian exits landmark Paris asset following successful repositioning strategy Ardian has completed...